Kirk Taylor is Senior Vice President of North American Medical Affairs (NAMA) at EMD Serono.
In this role, Kirk is responsible for leading the NAMA team with a focus on scientific communications, medical insights, and data generation to transform patient care. Kirk also serves as the Healthcare Representative to the Merck KGaA, Darmstadt, Germany Diversity Equity and Inclusion (DE&I) Council.
Prior to his current role, Kirk served as Senior Vice President, Medical Affairs Strategy and Operations for Verastem Oncology, where he was responsible for developing medical launch strategies and driving data generation. Kirk also served as Chief of Strategy and Late Phase Development as well as Chief Medical Officer for Finch Therapeutics Group.
Kirk brings strong expertise as a practicing neurologist combined with 22 years of global and U.S. drug development experience in Phases I-IV across multiple therapeutic areas including Neurology, Oncology, as well as rare diseases.
Kirk holds an M.D. from State University of New York Downstate and a B.A. from Harvard University. He completed a neurology residency at the Albert Einstein College of Medicine and a postdoc in neuropathic pain and headache from the University of California at San Francisco.